{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:31:29Z","timestamp":1791448289235,"version":"4.3.3"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Anaplastic thyroid carcinoma (ATC) is a highly aggressive malignancy, and there is currently a lack of up-to-date epidemiological data. Traditional survival analysis fails to capture the dynamic changes in prognosis for long-term survivors, while conditional survival (CS) analysis, a critical tool for adaptive risk stratification, remains underexplored in ATC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients diagnosed with ATC between 2000 and 2021 were identified from the Surveillance, Epidemiology, and End Results (SEER) database. Temporal trends in age-adjusted incidence and incidence-based mortality were analyzed using Joinpoint regression to calculate annual percentage changes (APCs) with 95% confidence intervals (CIs). Overall survival (OS) was estimated using the Kaplan-Meier method. CS rates were calculated using the formula: CS(y\/x) = OS(y+x)\/OS(x). Prognostic factors were identified using Best Subset Regression (BSR), LASSO, and univariate and multivariate Cox regression analyses, and these factors were incorporated into a CS-nomogram model. The predictive performance of the model was validated using evaluation metrics, including the area under the receiver operating characteristic curve (AUC). Point values were assigned to the model\u2019s predictive factors, and a risk stratification system was developed based on the optimal threshold of the total score.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>From 2000 to 2021, the age-adjusted incidence of ATC increased from 0.066 to 0.077 per 100,000 (APC: 2.308%, 95% CI: 1.187\u20133.441), peaking at 0.119 in 2018. Mortality trends paralleled this rise, with age-adjusted mortality increasing from 0.037 to 0.051 per 100,000 (APC: 2.380%, 95% CI: 1.129\u20133.646). CS analysis demonstrated a progressive increase in survival rates over time, with the 24-month cumulative survival rate rising from 14.0% to 93.8%, with the most pronounced temporal changes observed in patients with distant disease. Prognostic factors identified through BSR, LASSO, and Cox regression included age, SEER stage, and treatment. A novel CS-nomogram was successfully developed and validated for dynamic real-time survival prediction, enabling identification of high- and low-risk patient groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The incidence and incidence-based mortality of ATC have increased over the past few decades. The CS rates of ATC patients have dynamically improved over time. The CS-nomogram, integrating age, SEER stage, and treatment, provides clinicians with a personalized, dynamic, and real-time survival prediction tool that helps alleviate survivors\u2019 psychological distress, reduces anxiety, and optimizes precision follow-up strategies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1585679","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T04:15:02Z","timestamp":1749010502000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Trends in incidence, mortality, and conditional survival of anaplastic thyroid cancer over the last two decades in the USA"],"prefix":"10.3389","volume":"16","author":[{"given":"Hongpeng","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanji","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhencun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(24)00310-3","article-title":"Trends in incidence, metastasis, and mortality from thyroid cancer in the USA from 1975 to 2019: A population-based study of age, period, and cohort effects","volume":"13","author":"Chen","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.76","article-title":"Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies","volume":"13","author":"Molinaro","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid cancer incidence and mortality in the United States, 1974-2013","volume":"317","author":"Lim","year":"2017","journal-title":"Jama"},{"key":"B4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"B5","article-title":"The incidence and survival analysis for anaplastic thyroid cancer: A seer database analysis","volume":"11","author":"Lin","year":"2019","journal-title":"Am J Transl Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/542358","article-title":"Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment","volume":"2011","author":"Nagaiah","year":"2011","journal-title":"J Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104766","article-title":"Rare thyroid Malignancies in europe: data from the information network on rare cancers in europe (Rarecarenet)","volume":"108","author":"Locati","year":"2020","journal-title":"Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(21)00027-9","article-title":"Thyroid cancer incidence trends by histology in 25 countries: A population-based study","volume":"9","author":"Miranda-Filho","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14231","article-title":"Conditional survival and recurrence of remnant gastric cancer after surgical resection: A multi-institutional study","volume":"111","author":"Chen","year":"2020","journal-title":"Cancer Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1375176","article-title":"Development of a novel dynamic nomogram for predicting overall survival in anaplastic thyroid cancer patients with distant metastasis: A population-based study based on the seer database","volume":"15","author":"Wang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-024-02495-2","article-title":"Development and validation of a nomogram to predict overall survival in patients with redefined anaplastic thyroid carcinoma based on the seer database","volume":"29","author":"Zhang","year":"2024","journal-title":"Int J Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14729","article-title":"A novel prognostic model based on log odds of positive lymph nodes to predict outcomes of patients with anaplastic thyroid carcinoma after surgery","volume":"97","author":"Tang","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.7568","article-title":"Conditional survival and cure of patients with colon or rectal cancer: A population-based study","volume":"18","author":"Qaderi","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"B14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41408-023-00852-4","article-title":"Conditional survival in multiple myeloma and impact of prognostic factors over time","volume":"13","author":"Abdallah","year":"2023","journal-title":"Blood Cancer J"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.11476","article-title":"Conditional survival after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer","volume":"107","author":"Hagens","year":"2020","journal-title":"Br J Surg"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29049","article-title":"The surveillance, epidemiology, and end results (Seer) program of the national cancer institute","author":"Cronin","year":"2014","journal-title":"Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1097\/pas.0000000000000749","article-title":"The surveillance, epidemiology, and end results (Seer) program and pathology: toward strengthening the critical relationship","volume":"40","author":"Duggan","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(07)61602-x","article-title":"The strengthening the reporting of observational studies in epidemiology (Strobe) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12672-023-00839-4","article-title":"Dynamic estimates of survival in oncocytic cell carcinoma of the thyroid","volume":"14","author":"Shi","year":"2023","journal-title":"Discov Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28273","article-title":"Dynamic prognostication using conditional survival estimates","volume":"119","author":"Zabor","year":"2013","journal-title":"Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.18.2164","article-title":"Increasing incidence of thyroid cancer in the United States, 1973-2002","volume":"295","author":"Davies","year":"2006","journal-title":"Jama"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2012.0573","article-title":"Recent trends in the incidence, geographical distribution, and survival from thyroid cancer in wales, 1985-2010","volume":"23","author":"Amphlett","year":"2013","journal-title":"Thyroid"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/js9.0000000000002012","article-title":"Conditional survival analysis between primary squamous cell carcinoma of the thyroid and anaplastic thyroid carcinoma","volume":"111","author":"Xiang","year":"2024","journal-title":"Int J Surg"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1446312","article-title":"Tumor differentiation-dependent conditional survival of patients with operable thyroid cancer","volume":"15","author":"Yu","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-022-03085-w","article-title":"Risk stratification in patients with anaplastic thyroid carcinoma: role of age","volume":"77","author":"Wang","year":"2022","journal-title":"Endocrine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e9173","DOI":"10.7717\/peerj.9173","article-title":"Development and validation of a prognostic nomogram to predict overall survival and cancer-specific survival for patients with anaplastic thyroid carcinoma","volume":"8","author":"Gui","year":"2020","journal-title":"PeerJ"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0316","article-title":"Changes of clinicopathologic characteristics and survival outcomes of anaplastic and poorly differentiated thyroid carcinoma","volume":"26","author":"Lee","year":"2016","journal-title":"Thyroid"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21721","article-title":"Multimodality therapeutic outcomes in anaplastic thyroid carcinoma: improved survival in subgroups of patients with localized primary tumors","volume":"34","author":"Ito","year":"2012","journal-title":"Head Neck"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32548","article-title":"Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer","volume":"126","author":"Fan","year":"2020","journal-title":"Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0395","article-title":"Patterns of treatment failure in anaplastic thyroid carcinoma","volume":"27","author":"Rao","year":"2017","journal-title":"Thyroid"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.748023","article-title":"Radiotherapy plus chemotherapy leads to prolonged survival in patients with anaplastic thyroid cancer compared with radiotherapy alone regardless of surgical resection and distant metastasis: A retrospective population study","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0944","article-title":"2021 American thyroid association guidelines for management of patients with anaplastic thyroid cancer","volume":"31","author":"Bible","year":"2021","journal-title":"Thyroid"},{"key":"B33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12893-024-02375-6","article-title":"The value of multimodal treatment in anaplastic thyroid cancer patients with distant metastasis","volume":"24","author":"Guo","year":"2024","journal-title":"BMC Surg"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-023-03662-7","article-title":"Surgery combined with adjuvant radiation and chemotherapy prolonged overall survival in stage ivc anaplastic thyroid cancer: A seer-based analysis","volume":"85","author":"Yin","year":"2024","journal-title":"Endocrine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s12672-024-01537-5","article-title":"Development and validation of survival nomograms for patients with anaplastic thyroid carcinoma: A seer program-based study","volume":"15","author":"Chen","year":"2024","journal-title":"Discov Oncol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1585679\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T04:15:03Z","timestamp":1749010503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1585679\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":35,"alternative-id":["10.3389\/fendo.2025.1585679"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1585679","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"article-number":"1585679"}}